An edition of FDA integrity issues (1996)
FDA integrity issues
hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on VISX, Inc. document disclosure, July 31, 1996.
By United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
0 (0 Ratings)
0 Want to read0 Currently reading0 Have read
0 Want to read0 Currently reading0 Have read
Publish Date
1996
Publisher
U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
eng
Pages
83
Book Lists